EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $895 | -72.7% | 114,790 | -71.2% | 0.01% | -66.7% |
| Q2 2023 | $3,276 | +1730.2% | 398,091 | +1515.8% | 0.03% | +2600.0% |
| Q1 2023 | $179 | -100.0% | 24,637 | -45.9% | 0.00% | -85.7% |
| Q3 2022 | $557,000 | -46.1% | 45,521 | -47.9% | 0.01% | -46.2% |
| Q2 2022 | $1,034,000 | -24.2% | 87,429 | +70.2% | 0.01% | -7.1% |
| Q4 2021 | $1,364,000 | -34.1% | 51,369 | +2.0% | 0.01% | -50.0% |
| Q3 2021 | $2,069,000 | +646.9% | 50,365 | +662.3% | 0.03% | +600.0% |
| Q1 2021 | $277,000 | -5.5% | 6,607 | +58.2% | 0.00% | +33.3% |
| Q4 2020 | $293,000 | -77.8% | 4,176 | -91.1% | 0.00% | -88.5% |
| Q3 2020 | $1,319,000 | +75.2% | 47,019 | +84.7% | 0.03% | +30.0% |
| Q2 2020 | $753,000 | +52.4% | 25,456 | +52.5% | 0.02% | +122.2% |
| Q4 2019 | $494,000 | – | 16,697 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |